NO20083585L - Hetero-bisykliske antivirale forbindelser - Google Patents

Hetero-bisykliske antivirale forbindelser

Info

Publication number
NO20083585L
NO20083585L NO20083585A NO20083585A NO20083585L NO 20083585 L NO20083585 L NO 20083585L NO 20083585 A NO20083585 A NO 20083585A NO 20083585 A NO20083585 A NO 20083585A NO 20083585 L NO20083585 L NO 20083585L
Authority
NO
Norway
Prior art keywords
antagonists
ccr5
hetero
cyclic
antiviral compounds
Prior art date
Application number
NO20083585A
Other languages
English (en)
Inventor
Chris Richard Melville
Remy Lemoine
David Mark Rotstein
Jutta Wanner
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO20083585L publication Critical patent/NO20083585L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Kjemokinreseptor-antagonister, spesielt 3,7-diazabicyklo[3.3.0]oktan-forbindelser med formel (I), hvor R1-R3 R6c og X1 er som definert her, er antagonister av kjemokin-CCR5-reseptorer og er anvendelige for behandling eller forebygging av en infeksjon med humant immunsviktvirus (HIV-1-infeksjon) eller behandling av AIDS eller ARC. Oppfinnelsen tilveiebringer videre metoder for behandling av sykdommer som lindres av CCR5-antagonister. Oppfinnelsen omfatter farmasøytiske preparater og metoder for anvendelse av forbindelsene for behandling av sykdommer som er mediert av CCR5-reseptoren.
NO20083585A 2006-02-15 2008-08-19 Hetero-bisykliske antivirale forbindelser NO20083585L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77394206P 2006-02-15 2006-02-15
PCT/EP2007/051099 WO2007093520A1 (en) 2006-02-15 2007-02-06 Hetero-bycyclic antiviral compounds

Publications (1)

Publication Number Publication Date
NO20083585L true NO20083585L (no) 2008-10-28

Family

ID=38157829

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20083585A NO20083585L (no) 2006-02-15 2008-08-19 Hetero-bisykliske antivirale forbindelser

Country Status (16)

Country Link
US (1) US20070191335A1 (no)
EP (1) EP1987036A1 (no)
JP (1) JP2009526803A (no)
KR (1) KR20080102387A (no)
CN (1) CN101384596A (no)
AR (1) AR059571A1 (no)
AU (1) AU2007216543A1 (no)
BR (1) BRPI0710474A2 (no)
CA (1) CA2641389A1 (no)
CL (1) CL2007000362A1 (no)
IL (1) IL193107A0 (no)
NO (1) NO20083585L (no)
RU (1) RU2008136756A (no)
TW (1) TW200801010A (no)
WO (1) WO2007093520A1 (no)
ZA (1) ZA200806756B (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101384599A (zh) * 2006-02-15 2009-03-11 弗·哈夫曼-拉罗切有限公司 杂环抗病毒化合物
CA2662835A1 (en) 2006-09-18 2008-03-27 Remy Lemoine Octahydropyrrolo [3, 4-c] pyrrole derivatives and their use as antiviral agents
EP2099454A4 (en) * 2006-11-17 2010-11-10 Abbott Lab AMINOPYRROLIDINES AS CHEMOKINE RECEPTOR ANTAGONISTS
US8464207B2 (en) * 2007-10-12 2013-06-11 Novell Intellectual Property Holdings, Inc. System and method for tracking software changes
DE102010025663A1 (de) * 2010-06-30 2012-01-05 Karl-Heinz Glüsenkamp Neue beta-Aminoaldehyd-Derivate, Verfahren zu ihrer Herstellung und ihre chemische Verwendung als reaktive Intermediate
CN104039770A (zh) 2011-11-14 2014-09-10 巴斯夫欧洲公司 取代的1,2,5-噁二唑化合物及其作为除草剂的用途
IN2014MN02211A (no) 2012-04-27 2015-07-10 Basf Se
EP2855463B1 (en) 2012-04-27 2018-08-01 Basf Se Substituted n-(tetrazol-5-yl)- and n-(triazol-5-yl)arylcarboxamide compounds and their use as herbicides
CN102718695B (zh) * 2012-06-25 2014-04-02 华东师范大学 一种氮杂双环[3.3.0]辛烷衍生物的合成方法
AR092211A1 (es) * 2012-09-24 2015-04-08 Merck Patent Ges Mit Beschränkter Haftung Derivados de hidropirrolopirrol
WO2014184058A1 (en) 2013-05-15 2014-11-20 Basf Se Substituted 1,2,5-oxadiazole compounds and their use as herbicides
UA116021C2 (uk) 2013-05-15 2018-01-25 Басф Се Заміщені n-(тетразол-5-іл)- й n-(триазол-5-іл)арилкарбоксамідні сполуки та їх застосування як гербіцидів
CN105377836B (zh) 2013-07-18 2018-04-10 巴斯夫欧洲公司 取代的n‑(1,2,4‑三唑‑3‑基)芳基羧酰胺化合物及其作为除草剂的用途
WO2015052153A1 (en) 2013-10-10 2015-04-16 Basf Se Substituted n-(tetrazol-5-yl)- and n-(triazol-5-yl)arylcarboxamide compounds and their use as herbicides
WO2015052173A1 (en) 2013-10-10 2015-04-16 Basf Se Tetrazole and triazole compounds and their use as herbicides
WO2015052178A1 (en) 2013-10-10 2015-04-16 Basf Se 1,2,5-oxadiazole compounds and their use as herbicides
EP2907807A1 (en) 2014-02-18 2015-08-19 Basf Se Benzamide compounds and their use as herbicides
WO2017102275A1 (en) 2015-12-17 2017-06-22 Basf Se Benzamide compounds and their use as herbicides
CA3030381A1 (en) 2016-07-14 2018-01-18 Pfizer Inc. Pyrimidine carboxamides as inhibitors of vanin-1 enzyme
EP3630734A1 (en) 2017-05-30 2020-04-08 Basf Se Benzamide compounds and their use as herbicides
AU2018276360A1 (en) 2017-05-30 2019-12-19 Basf Se Benzamide compounds and their use as herbicides II
AR112112A1 (es) 2017-06-20 2019-09-18 Basf Se Compuestos de benzamida y su uso como herbicidas
AR112342A1 (es) 2017-07-21 2019-10-16 Basf Se Compuestos de benzamida y su uso como herbicidas
AR114040A1 (es) 2017-12-22 2020-07-15 Basf Se Compuestos de benzamida y su uso como herbicidas
WO2019162308A1 (en) 2018-02-21 2019-08-29 Basf Se Benzamide compounds and their use as herbicides
WO2019162309A1 (en) 2018-02-21 2019-08-29 Basf Se Benzamide compounds and their use as herbicides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005121145A2 (en) * 2004-06-09 2005-12-22 F. Hoffmann-La Roche Ag Octahydro-pyrrolo[3,4-c] derivatives and their use as antiviral compounds

Also Published As

Publication number Publication date
TW200801010A (en) 2008-01-01
AU2007216543A1 (en) 2007-08-23
IL193107A0 (en) 2009-02-11
US20070191335A1 (en) 2007-08-16
EP1987036A1 (en) 2008-11-05
CL2007000362A1 (es) 2008-01-11
RU2008136756A (ru) 2010-03-20
CN101384596A (zh) 2009-03-11
JP2009526803A (ja) 2009-07-23
ZA200806756B (en) 2009-11-25
WO2007093520A1 (en) 2007-08-23
KR20080102387A (ko) 2008-11-25
AR059571A1 (es) 2008-04-16
CA2641389A1 (en) 2007-08-23
BRPI0710474A2 (pt) 2011-08-16

Similar Documents

Publication Publication Date Title
NO20083585L (no) Hetero-bisykliske antivirale forbindelser
NO20070137L (no) Heterocykliske antivirale forbindelser
EA200701324A1 (ru) Соединения пиридина для лечения заболеваний, опосредованных действием простагландина
NO20083583L (no) Heterosykliske antivirale forbindelser
NO20082135L (no) HIV integrase inhibitorer
TW200600503A (en) Bicyclic heterocycles as hiv integrase inhibitors
TW200738728A (en) HIV integrase inhibitors
WO2009146555A8 (en) Hiv integrase inhibitors from pyridoxine
TW200837074A (en) Extended triterpene derivatives
NO20060195L (no) Kinolylamidderivater som CCR-5-antagonister
IL180495A (en) Benzyl triazolone compounds as non-nucleotide reverse transcriptase inhibitors
EP2041159B8 (en) Macrocyclic compounds as antiviral agents
AP1789A (en) Tropane derivatives useful in therapy.
DE60224404D1 (de) Substiuierte piperidine als melanocortinrezeptor-modulatoren
ATE384724T1 (de) Cyclopropylverbindungen als ccr5 antagonisten
NO20071246L (no) Kinazolinonderivater og deres anvendelse som B-RAF-inhibitorer.
WO2008002959A3 (en) Hiv integrase inhibitors
MX2012000565A (es) Derivados de triterpeno tipo lupeol como antivirales.
NO20070199L (no) Substituerte kinazoloner som anti-kreftmidler
EA200600480A1 (ru) Имидазопиридинзамещённые тропановые производные, обладающие активностью антагониста ccr5 рецептора, для лечения вируса иммунодефицита человека (вич) и воспаления
ATE498630T1 (de) Arylalkyl- und heteroarylalkyl-derivate von cyclosporin a bei der behandlung und vorbeugung einer virusinfektion
NO20080797L (no) Bicykliske heterocykler som HIV Integrase inhibitorer
NO20085100L (no) Nye forbindelser
NO20081844L (no) Terapeutiske forbindelser
EA200802007A1 (ru) Соединения, потенцирующие рецептор амра, и применение указанных соединений в медицине